Effects of various in vitro--inhibitors of benzo(a)pyrene metabolism in isolated rat lung perfusion. 1979

K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki

Various in vitro-inhibitors were added with 3H-benzo(a)pyrene (BP) into the perfusion fluids in isolated rat lung perfusions to see whether their effects are dependent on the integrity of tissue. 3H-BP and its metabolites were measured by thin-layer chromatography and radiometry from both samples of perfusion medium and homogenates of lung tissue. The total covalent binding to lung tissue was used as a measure of the formation of reactive metabolites. In methylcholanthrene-induced rat lung, the metabolism of BP was inhibited by alpha-naphthoflavone, an inhibitor of monooxygenase, and less with diethylmaleate, a depletor of glutathione, with salicylamide, an inhibitor of conjugases, and, astonishingly, with D-saccharo-1,4-lactone, an inhibitor of beta-glucuronidase. With trichloropropene oxide, which inhibits epoxide hydratase, the metabolism was either decreased or unchanged. Nicotine had no effect on BP-metabolism. Nicotine and diethylmaleate increased statistically significantly and alpha-naphthoflavone and salicylamide decreased the covalent binding of radioactivity to lung tissue. In most cases, the changes in BP metabolism observed during perfusion can be explained on the basis of effects of modifiers on the enzyme systems.

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008298 Maleates Derivatives of maleic acid (the structural formula (COO-)-C
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D005966 Glucuronidase Endo-beta-D-Glucuronidase,Endoglucuronidase,Exo-beta-D-Glucuronidase,beta-Glucuronidase,Endo beta D Glucuronidase,Exo beta D Glucuronidase,beta Glucuronidase
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine

Related Publications

K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
August 1987, Toxicology,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
June 1987, Archives of toxicology,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
December 1983, Experimental lung research,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
May 1979, Biochemical pharmacology,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
January 1978, Drug metabolism and disposition: the biological fate of chemicals,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
April 1983, The Journal of pharmacology and experimental therapeutics,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
September 1980, Cancer research,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
March 1972, Experientia,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
January 1981, Advances in experimental medicine and biology,
K Vähäkangas, and K Nevasaari, and O Pelkonen, and N T Kärki
January 1983, Chemico-biological interactions,
Copied contents to your clipboard!